Product Categories
| Country: | United States |
|---|---|
| Tel: | 552-7181 |
| E-mail: | sales@aladdinsci.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 14078 Meridian Parkway, Riverside |
|
Aladdin Scientific Corporation is a listed company on the A-share Science and Technology Board (stock code: 688179), which has been deeply engaging in the field of scientific research reagents for more than ten years, and is a manufacturer of scientific research reagents integrating research and development, production and sales. After years of exploration, accumulation and development, it owns six major product lines of chemistry and biochemistry reagents, material sciences, drug-targeting ligands, proteins, antibodies, and I-Quip?? labware. Product line.
Relying on its own e-commerce platform (www.aladdinsci.com), Aladdin provides a huge product line covering hundreds of thousands of scientific research reagents and thousands of consumables/instruments, which are widely used in colleges and universities, scientific research institutes, medical treatment, medicine, pharmaceuticals, diagnostics, new materials, new energy, energy conservation and environmental protection, aerospace and other high-tech industries as well as their upstream and downstream enterprises. Corporation
|
|
| Product Name | MF | CAS | Details |
|---|
| NLRP3/AIM2-IN-2 | C15H15NO3 | 791840-86-3 | Details |
| NS2B/NS3-IN-3 | C19H21N3O2 | 2832876-90-9 | Details |
| NU6300 | C20H23N5O3S | 2070015-09-5 | Details |
| NRC-2694 | C24H26N4O3 | 936446-61-6 | Details |
| 4-Nonylphenol-d5 | C15H19D5O | 358730-95-7 | Details |
| Nateglinide-d5 | C19H22D5NO3 | 1227666-13-8 | Details |
| NVS-SM2 | C23H30N6O | 1562333-92-9 | Details |
| NF-κΒ activator 1 | C16H11FN2O2S | 2387524-59-4 | Details |
| Nemorubicin | C32H37NO13 | 108852-90-0 | Details |
| NLRP3-IN-11 | C17H17ClN4O2 | 2769040-91-5 | Details |
| N-Nornuciferine | C18H19NO2 | 4846-19-9 | Details |
| NSP-AS | C28H28N2O8S2 | 211106-69-3 | Details |
| Namitecan | C23H22N4O5 | 372105-27-6 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| Nav1.7-IN-2 | C22H22FN5O2 | 1332295-35-8 | Details |
| N3-PEG3-CH2CH2COOH | C9H17N3O5 | 1056024-94-2 | Details |
| Nelonemdaz potassium | C15H9F7KNO3 | 916214-57-8 | Details |
| NFAT Transcription Factor Regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| NAMPT inhibitor-linker 1 | C36H37FN6O6 | 2241019-57-6 | Details |
| NVP-BHG712 isomer | C26H20F3N7O | 2245892-85-5 | Details |
| Nampt-IN-3 | C29H25N7O2 | 2121591-52-2 | Details |
| NMS-P515 | C21H29N3O2 | 1262395-13-0 | Details |
| Neocryptotanshinone | C19H22O4 | 109664-02-0 | Details |
| NCGC00244536 | C25H22N2O2 | 2003260-55-5 | Details |
| Nicodicosapent | C28H39N3O2 | 1269181-69-2 | Details |
| NucPE1 | C29H30BNO5 | 1404091-23-1 | Details |
| Naphthoquine phosphate | C24H31ClN3O5P | 173531-58-3 | Details |
| NaV1.7 inhibitor-1 | C23H30FNO4S | 1494585-79-3 | Details |
| Niga-ichigoside F1 | C36H58O11 | 95262-48-9 | Details |
| Nodosin | C20H26O6 | 10391-09-0 | Details |
| Nelociguat | C19H17FN8O2 | 625115-52-8 | Details |
| NCRW0005-F05 | C16H13F2NO2 | 342779-66-2 | Details |
| NVX-207 | C36H59NO6 | 745020-66-0 | Details |
| NHWD-870 | C29H29N7O | 2115742-03-3 | Details |
| N-β-alanyldopamine hydrochloride | C11H17ClN2O3 | 58077-93-3 | Details |
| Nuvenzepine | C19H20N4O2 | 96487-37-5 | Details |
| NSC 694623 | C16H16N2OS | 907957-34-0 | Details |
| NK1 receptor antagonist 2 | C31H35F7N4O2 | 579475-17-5 | Details |
| N-Feruloyloctopamine | C18H19NO5 | 66648-44-0 | Details |
| N-(3-Methoxybenzyl)Palmitamide | C24H41NO2 | 847361-96-0 | Details |
| N-Desethyl amodiaquine dihydrochloride | C18H20Cl3N3O | 79049-30-2 | Details |
| Niraparib (R-enantiomer) | C19H20N4O | 1038915-58-0 | Details |
| N-deacetylated BMS-202 | C23H27N3O2 | 2310135-18-1 | Details |
| Neoseptin 3 | C29H34N2O4 | 1622863-21-1 | Details |
| NCGC00029283 | C18H12FN3O3 | 714240-31-0 | Details |
| NF-56-EJ40 | C27H29N3O3 | 2380230-73-7 | Details |
| Nav1.1 activator 1 | C24H23F3N4O | 2332897-85-3 | Details |
| NSC 694621 | C13H10N2O2S | 104857-29-6 | Details |
| N1,N3,N5-Tris(4-dodecylhexadecyl)benzene-1,3,5-tricarboxamide | C93H177N3O3 | 2922283-38-1 | Details |
| N-p-trans-Coumaroyltyramine | C17H17NO3 | 36417-86-4 | Details |
| NPPM 6748-481 | C17H15ClFN3O3 | 432020-20-7 | Details |
| NMS-P715 | C35H39F3N8O3 | 1202055-32-0 | Details |
| Nampt-IN-1 | C20H25N3O5S | 1698878-14-6 | Details |
| NHS-SS-Ph | C16H17NO7S2 | 2750799-12-1 | Details |
| NRX-2663 | C20H13F3N2O5 | 2763260-34-8 | Details |
| NCI172112 | C14H23Cl2N3O2 | 56605-16-4 | Details |
| Nrf2 activator-4 | C23H24ClF3N2O3 | 2383016-68-8 | Details |
| Nevadensin | C18H16O7 | 10176-66-6 | Details |
| Naquotinib mesylate | C31H46N8O6S | 1448237-05-5 | Details |
| Norwogonin | C15H10O5 | 4443-09-8 | Details |
| NRX-252262 | C23H17Cl2F3N2O4S | 2438637-61-5 | Details |
| NPD-1335 | C28H29N3O3 | 2376326-31-5 | Details |
| (Rac)-NMDAR antagonist 1 | C20H20BrN3O2 | 2435557-99-4 | Details |
| Necroptosis-IN-1 | C12H10ClN3O2 | 1391980-92-9 | Details |
| Niclosamide-13C6 | C13H8Cl2N2O4 | 1325808-64-7 | Details |
| N-(3-Methoxybenzyl)-(9Z,12Z,15Z)-octadecatrienamide | C26H39NO2 | 883715-23-9 | Details |
| Naproxen etemesil | C17H20O5S | 385800-16-8 | Details |
| [Leu31,Pro34]-Neuropeptide Y (porcine) | C190H286N54O56 | 125580-28-1 | Details |
| NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
| N-[(4-Aminophenyl)methyl]adenosine | C17H20N6O4 | 95523-13-0 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| Narmafotinib | C28H32F3N5O2 | 1393653-34-3 | Details |
| NCT02 | C17H16N2O2S | 790245-61-3 | Details |
| N-ε-propargyloxycarbonyl-L-lysine hydrochloride | C10H16N2O4 | 1428330-91-9 | Details |
| NAI-N3 | C10H8N6O | 1612756-29-2 | Details |
| Nucleoprotein (396-404) | C50H71N13O14 | 158475-79-7 | Details |
| Nigranoic acid | C30H46O4 | 39111-07-4 | Details |
| NSC 601980 | C15H12N4 | 2070018-27-6 | Details |
| NFATc1-IN-1 | C13H8F2INO2 | 1912422-56-0 | Details |
| NUCC-390 dihydrochloride | C23H34ClN5O | 2749281-71-6 | Details |
| Nagilactone B | C19H24O7 | 19891-51-1 | Details |
| Nigakinone | C15H10N2O3 | 18110-86-6 | Details |
| Notoginsenoside R2 | C41H70O13 | 80418-25-3 | Details |
| N-acetyl Dapsone-d4 | C14H10D4N2O3S | 2070015-08-4 | Details |
| Niraparib metabolite M1 | C19H19N3O2 | 1476777-06-6 | Details |
| NLRP3-IN-13 | C19H15N3O3S | 1704638-35-6 | Details |
| NS3861 | C12H14BrNS | 216853-59-7 | Details |
| NF-κB/MAPK-IN-1 | C27H27NO7 | 2413940-56-2 | Details |
| N6-(4-Hydroxybenzyl)adenosine | C17H19N5O5 | 110505-75-4 | Details |
| β-Neo-Endorphin | C54H77N13O12 | 77739-21-0 | Details |
| Nitecapone | C12H11NO6 | 116313-94-1 | Details |
| N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium | C21H32N11O17P3 | 75252-10-7 | Details |
| NH-3 | C28H27NO6 | 447415-26-1 | Details |
| NMDI14 | C21H25N3O4S | 307519-88-6 | Details |
| NRP1 antagonist 1 | C22H22N6OS2 | 2569598-01-0 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| NHE3-IN-2 | C15H12ClN5 | 92434-13-4 | Details |
| NSP-805 | C17H19N3O2 | 125068-54-4 | Details |
| NSC639828 | C18H13BrClN5O3 | 134742-26-0 | Details |
| N-Boc-Phe-Leu-Phe-Leu-Phe | C44H59N5O8 | 148182-34-7 | Details |
| Product Total： Product Page： | ||||
| 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 | ||||